Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,132.09
(
0.32%
)
US TECH 100
25,953.60
(
0.32%
)
Dow Jones
49,791.06
(
0.69%
)
Brent Oil
91.95
(
1.41%
)
Bitcoin
75,891.93
(
0.00%
)
News Focus
News Focus
Post# of 257432
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: alertmeipp post# 51496

Friday, 08/24/2007 10:12:42 PM

Friday, August 24, 2007 10:12:42 PM

Post# of 257432
>But if you think Stoll's lying, then that's another story.<

Most biotech CEO’s choose their words carefully in front of investors. They know that saying there are term sheets for a drug candidate is sufficiently vague to not be an actionable offense. Disclosing the mere existence of term sheets without disclosing the terms themselves is not a material item, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up